In dogs with CS, hyperlipidemia can result from downregulation of LDL receptors and decreased liver uptake of LDL and/or development of insulin resistance, which impairs lipoprotein lipase activity [14,15]. The gene discussed is LDLR; the disease is hyperlipidemia.